Healthcare investing has been challenging this year, with rising claims and medical costs leading to significant losses for insurers like UnitedHealth Group, whose stock has dropped 35%. Despite these challenges, Oscar Health (NYSE: OSCR), an emerging insurer targeting the individual market, is poised for a turnaround, projecting profitability by 2026. The company faces the same cost pressures as its competitors but benefits from strong long-term growth potential. Oscar Health is considered a promising value stock for future economic shifts, despite current unprofitability.
